| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RMD | ResMed Common Stock | Award | $18.2M | +71.3K | +17.13% | $254.81 | 487K | 16 Nov 2021 | Direct | F1 |
| transaction | RMD | ResMed Common Stock | Tax liability | -$10.8M | -42.2K | -8.66% | $254.81 | 445K | 17 Nov 2021 | Direct | F2 |
| transaction | RMD | ResMed Common Stock | Award | $0 | +4.47K | +1% | $0.00 | 449K | 18 Nov 2021 | Direct | F3 |
| transaction | RMD | ResMed Common Stock | Gift | $0 | -44.3K | -9.84% | $0.00 | 405K | 19 Nov 2021 | Direct | F4 |
| holding | RMD | ResMed Common Stock | 8.97K | 16 Nov 2021 | Lisette and Michael Farrell Family Trust |
| Id | Content |
|---|---|
| F1 | Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on November 16, 2021, when the compensation committee certified that the performance metrics were met. |
| F2 | Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018. |
| F3 | Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. |
| F4 | Gift of shares to the Farrell Legacy Trust. Mr. Farrell has no beneficial interest, control or dispositive power over the gifted shares. |